Ulcerative Colitis Induced by Secukinumab in the Treatment of Ankylosing Spondylitis
Interleukin 17 (IL-17) inhibitors are approved for treating psoriasis, psoriatic arthropathy, and ankylosing spondylitis. IL-17 is involved in the pathogenesis of inflammatory bowel disease (IBD); however, paradoxical events have been reported using selective IL-17 inhibitors such as secukinumab, wh...
Uloženo v:
| Vydáno v: | Revista Colombiana de Gastroenterología |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Asociación Colombiana de Gastroenterologia
2023
|
| Témata: | |
| On-line přístup: | https://www.redalyc.org/articulo.oa?id=337779447011 https://www.redalyc.org/journal/3377/337779447011/ https://www.redalyc.org/journal/3377/337779447011/html/ https://www.redalyc.org/journal/3377/337779447011/337779447011.epub https://www.redalyc.org/journal/3377/337779447011/movil |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|